2024 Wisconsin Multiple Myeloma & Lymphoma Summit

By -Elaina Harris

May 20, 2024

This CME-accredited activity, Wisconsin Multiple Myeloma & Lymphoma Summit, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia.

This activity aims to improve learners’ knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care

Job Application

Job Application

Abstract Presenters Showcase Cancer Disparities Research at the 2024 Summit on Cancer Health Disparities

Abstract Presenters Showcase Cancer Disparities Research at the 2024 Summit on Cancer Health Disparities